The Strategic Rise of India's Deep-Science Economy

India is emerging as a powerful hub for deep science and biotechnology, driven by favourable geopolitics, a large domestic market, strong pharmaceutical and chemicals infrastructure, and supportive government policies.

- 

With initiatives such as the $12 billion Research, Development and Innovation (RDI) Fund, the BioE3 policy, and regulatory support for advanced genetic technologies, the country is positioning itself for rapid innovation-led growth. A growing talent pool, returning global expertise, expanding pharma GCCs, and capital-efficient manufacturing further strengthen India's advantage. Together, these factors create a strong foundation for globally competitive, sustainable science-driven enterprises.

India’s biotech industry is currently undergoing a long awaited shift from being the generics capital of the world to an innovation hub. More than $900 million have been invested into cutting edge IP led startups in therapeutics, diagnostics and industrial biotech over the last seven years, according to Ankur Capital’s Deep Science Tech Report 2025. The journey of deep science biotechnology driven startups in India began in the early 2010’s with companies such as String Bio, Bugworks and Zumutor Biologics pushing the boundaries to develop novel drugs and agri inputs using synthetic biology and precision fermentation. While their journey has been long and hard and yet to see large outcomes, they laid the foundations for cutting edge innovations in biotechnology emerging from India for the world.